Product Images Estradiol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 17 images provide visual information about the product associated with Estradiol NDC 68968-3450 by Noven Therapeutics, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

chemical structure - estradiol figure 1

chemical structure - estradiol figure 1

Figure D - estradiol figure 10

Figure D - estradiol figure 10

Figure E, F - estradiol figure 11

Figure E, F - estradiol figure 11

Figure G - estradiol figure 12

Figure G - estradiol figure 12

0.025 mg Pouch Label - estradiol figure 13

0.025 mg Pouch Label - estradiol figure 13

The text seems to be a product description of a hormonal transdermal patch containing 0.41mg of estradiol US that is applied twice-weekly. It comes in a package that contains 8 systems and should be immediately applied after removal from the pouch. The inactive components include acrylic adhesive, silicone adhesive, and others. The patch should be kept out of reach of children and stored at 20°C to 25°C. It includes dosage and administrative instructions, a barcode, and a pharmaceutical company's details.*

0.025 mg 8-count Carton Label - estradiol figure 14

0.025 mg 8-count Carton Label - estradiol figure 14

0.0375 mg Pouch Label - estradiol figure 15

0.0375 mg Pouch Label - estradiol figure 15

This is a description of a transdermal system that delivers 0.05 mg/day of Estradiol, an inactive component containing silicone adhesive, povidone, polyolefin laminating, polyester release, and 8 systems. The package insert has information on dosage and administration. The system is for transdermal use only and should be kept out of the reach of children. It is important to apply immediately upon removal from pouch and should not be stored unpouched. The recommended storage temperature is 20°C to 25°C.*

0.0375 mg 8-count Carton Label - estradiol figure 16

0.0375 mg 8-count Carton Label - estradiol figure 16

0.050 mg Pouch Label - estradiol figure 17

0.050 mg Pouch Label - estradiol figure 17

This is a product description of Estradiol, a transdermal system designed for topical use twice-weekly. It contains 1.65 mg of estradiol USP and comes in a package of eight systems. The product's active components are acrylic adhesive, silicone adhesive, oleyl alcohol, dipropylene glycol, povidone, polyolefin laminate backing, polyester release liner. It should be stored at 20°C to 26°C and must be kept out of reach of children. The text also contains some unreadable characters and may be a result of errors.*

layers - estradiol figure 2

layers - estradiol figure 2

The product is an adhesive that contains estradiol and has a protective liner.*

figure1 - estradiol figure 3

figure1 - estradiol figure 3

The text describes a graph showing serum concentration in pg/mL over time (in days) for a medication that is administered at three different doses: 0.1mg/day, 0.05mg/day, and 0.25mg/day. The graph shows that the higher the dosage, the higher the serum concentration of the medication. However, without more information, it is impossible to determine what medication is being administered or why it is being administered at different doses.*

figure2 - estradiol figure 4

figure2 - estradiol figure 4

This appears to be a table displaying the results of a study with different measurements taken at week 4, week 8, and week 12. There are two groups being compared, one receiving a medication called Vivelle and the other receiving a placebo. The numbers in the table seem to represent the values for each measurement with their corresponding sample sizes. There is also a note indicating a statistically significant difference between the Vivelle and placebo groups.*

figure3 - estradiol figure 5

figure3 - estradiol figure 5

This table shows the percentage change from the baseline at different time points during a treatment duration of 104 weeks. The treatments compared are Vivelle at doses of 0.1mg/day, 0.025mg/day, 0.05mg/day, and 0.0375mg/day, as well as a placebo. However, no actual percentage values are provided, so the efficacy of the different treatments cannot be determined from this information alone.*

figure4 - estradiol figure 6

figure4 - estradiol figure 6

This text appears to be a table or chart that includes information on various treatments and their impact at different time intervals. It is not clear what the treatments are for or what the percentages and symbols indicate. The text does not provide enough context to generate a useful description.*

Figure A - estradiol figure 7

Figure A - estradiol figure 7

Figure B - estradiol figure 8

Figure B - estradiol figure 8

Figure C - estradiol figure 9

Figure C - estradiol figure 9

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.